CD4 and autoimmune disease: To identify predictive biomarkers linked to clinical outcome and novel therapeutic targets in autoimmune patients, McKinney et al. undertook an unbiased genomic analysis of CD4+ and CD8+ T cells from patients suffering from various autoimmune diseases.31 The authors demonstrated that the level of T-cell exhaustion in autoimmune patients was strongly correlated with their clinical outcomes.